Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $34.41B | $310.67 | $390.88 | 25.82% | Strong Buy | 8 | 120.82% | 371.20% | 3,252.07% | 1,759.41% | |||
| CORT | CORCEPT THERAPEUTICS INC | $9.18B | $87.30 | $135.33 | 55.02% | Strong Buy | 3 | 29.54% | 64.46% | 137.93% | 105.82% | |||
| NVO | NOVO NORDISK A S | $223.82B | $50.37 | $57.40 | 13.96% | Buy | 5 | 91.01% | 91.94% | 481.51% | 159.69% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $51.72B | $391.50 | $491.28 | 25.49% | Strong Buy | 25 | 29.56% | 243.78% | 1,231.98% | 59.39% | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $459.95M | $8.17 | $23.00 | 181.52% | Strong Buy | 4 | 37.72% | 50.55% | 113.63% | 56.02% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.15B | $41.55 | $51.33 | 23.55% | Strong Buy | 6 | 20.26% | 66.86% | 41.88% | 31.47% | |||
| GMAB | GENMAB A | $20.27B | $31.57 | $43.75 | 38.58% | Strong Buy | 4 | 11.41% | 110.43% | 34.97% | 28.64% | |||
| ARGX | ARGENX SE | $51.94B | $850.95 | $1.04k | 22.00% | Strong Buy | 14 | 1,457.11% | 14.48% | 43.41% | 36.87% | |||
| LGND | LIGAND PHARMACEUTICALS INC | $3.80B | $192.88 | $239.33 | 24.08% | Strong Buy | 6 | 7.08% | 60.68% | 23.49% | 15.12% | |||
| VCEL | VERICEL CORP | $1.85B | $36.49 | $58.33 | 59.86% | Strong Buy | 3 | 14.99% | 53.81% | 27.97% | 19.86% | |||
| TECH | BIO-TECHNE CORP | $9.14B | $58.69 | $70.33 | 19.84% | Strong Buy | 9 | 6.53% | 73.40% | 20.97% | 16.32% | |||
| RPRX | ROYALTY PHARMA PLC | $22.24B | $38.53 | $45.75 | 18.74% | Strong Buy | 4 | 12.69% | 49.79% | 41.62% | 20.69% | |||
| KRYS | KRYSTAL BIOTECH INC | $7.05B | $242.98 | $213.17 | -12.27% | Buy | 6 | 26.15% | 11.01% | 44.02% | 40.39% | |||
| VCYT | VERACYTE INC | $3.44B | $43.53 | $45.50 | 4.53% | Buy | 6 | 8.74% | 48.66% | 13.77% | 12.66% | |||
| CRMD | CORMEDIX INC | $892.68M | $11.33 | $18.40 | 62.40% | Buy | 5 | 28.50% | 0.19% | 64.44% | 32.11% | |||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.07B | $15.69 | $17.25 | 9.94% | Buy | 4 | 11.97% | 20.64% | 46.60% | 32.31% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $10.01B | $52.12 | $84.64 | 62.39% | Strong Buy | 11 | 6.50% | 26.19% | 22.03% | 17.52% | |||
| HALO | HALOZYME THERAPEUTICS INC | $7.46B | $63.45 | $77.13 | 21.55% | Buy | 8 | 16.28% | 26.14% | 241.37% | 54.76% | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $139.93M | $1.74 | $12.00 | 589.66% | Buy | 1 | 4.68% | 38.79% | 29.17% | 18.76% | |||
| GYRE | GYRE THERAPEUTICS INC | $726.35M | $7.54 | $17.00 | 125.46% | Strong Buy | 2 | 13.27% | 13.62% | 218.85% | 139.94% | |||
| EXEL | EXELIXIS INC | $11.09B | $41.38 | $45.82 | 10.74% | Buy | 17 | 10.03% | 16.60% | 58.25% | 44.57% | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.24B | $38.92 | $45.00 | 15.62% | Strong Buy | 6 | 11.83% | 15.35% | 69.43% | 47.99% | |||
| MNKD | MANNKIND CORP | $1.82B | $5.94 | $10.08 | 69.75% | Strong Buy | 6 | 15.24% | 23.35% | -326.91% | 29.44% | |||
| INCY | INCYTE CORP | $19.37B | $98.64 | $98.63 | -0.02% | Buy | 16 | 8.61% | 14.93% | 43.11% | 31.67% | |||
| INVA | INNOVIVA INC | $1.51B | $20.14 | $32.00 | 58.89% | Buy | 4 | 7.03% | 6.45% | 20.54% | 14.52% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $115.62B | $455.71 | $489.58 | 7.43% | Buy | 19 | 7.35% | 16.60% | 36.72% | 25.58% | |||
| ADMA | ADMA BIOLOGICS INC | $4.70B | $19.73 | N/A | N/A | N/A | N/A | 19.16% | 13.23% | 94.87% | 71.93% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $508.37M | $6.37 | $13.00 | 104.08% | Strong Buy | 2 | 14.33% | 17.78% | 72.56% | 52.26% | |||
| UTHR | UNITED THERAPEUTICS CORP | $21.54B | $500.30 | $495.08 | -1.04% | Buy | 12 | 6.28% | 3.42% | 24.64% | 22.09% | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.97B | $24.18 | $33.00 | 36.48% | Strong Buy | 1 | 5.48% | 3.61% | 49.18% | 43.04% | |||
| REGN | REGENERON PHARMACEUTICALS INC | $79.10B | $752.62 | $787.63 | 4.65% | Buy | 16 | 5.27% | 6.76% | 19.10% | 14.72% | |||
| MDXG | MIMEDX GROUP INC | $1.05B | $7.12 | $12.00 | 68.54% | Strong Buy | 1 | 6.10% | 11.26% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.